Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 4
1993 1
1994 2
1995 1
1996 4
1997 2
1998 2
1999 4
2000 7
2001 3
2002 6
2003 7
2004 12
2005 13
2006 18
2007 15
2008 17
2009 18
2010 18
2011 14
2012 21
2013 27
2014 17
2015 12
2016 16
2017 13
2018 7
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

264 results
Results by year
Filters applied: . Clear all
Page 1
Ulcerative colitis.
Adams SM, Bornemann PH. Adams SM, et al. Am Fam Physician. 2013 May 15;87(10):699-705. Am Fam Physician. 2013. PMID: 23939448 Free article. Review.
First-line treatment is therapy with 5-aminosalicylic acid. Corticosteroids may be added if 5-aminosalicylic acid therapy is ineffective. ...Patients with ulcerative colitis have an increased risk of colon cancer and should …
First-line treatment is therapy with 5-aminosalicylic acid. Corticosteroids may be added if 5-aminosalicylic
A comprehensive review and update on ulcerative colitis.
Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. Gajendran M, et al. Dis Mon. 2019 Dec;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. Epub 2019 Mar 2. Dis Mon. 2019. PMID: 30837080 Review.
For proctitis, topical 5-aminosalicylic acid (5-ASA) drugs are used as the first line agents. UC patients with more extensive or severe disease should be treated with a combination of oral and topical 5-ASA drugs +/- corticosteroids to induce re …
For proctitis, topical 5-aminosalicylic acid (5-ASA) drugs are used as the first line agents. UC patients with m …
ACG Clinical Guideline: Ulcerative Colitis in Adults.
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. Rubin DT, et al. Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152. Am J Gastroenterol. 2019. PMID: 30840605
Ulcerative colitis: epidemiology, diagnosis, and management.
Feuerstein JD, Cheifetz AS. Feuerstein JD, et al. Mayo Clin Proc. 2014 Nov;89(11):1553-63. doi: 10.1016/j.mayocp.2014.07.002. Epub 2014 Sep 8. Mayo Clin Proc. 2014. PMID: 25199861 Review.
In the right clinical setting, the diagnosis of ulcerative colitis is based primarily on endoscopy, which typically reveals evidence of continuous colonic inflammation, with confirmatory biopsy specimens having signs of chronic colitis. ...Treatment is determined on the ba …
In the right clinical setting, the diagnosis of ulcerative colitis is based primarily on endoscopy, which typically reveals evidence of cont …
Intestinal inflammation and cancer.
Ullman TA, Itzkowitz SH. Ullman TA, et al. Gastroenterology. 2011 May;140(6):1807-16. doi: 10.1053/j.gastro.2011.01.057. Gastroenterology. 2011. PMID: 21530747 Review.
The risk for colon cancer increases with the duration and anatomic extent of colitis and presence of other inflammatory disorders (such as primary sclerosing cholangitis), whereas it decreases when patients take drugs to reduce inflammation (such as mesalamine
The risk for colon cancer increases with the duration and anatomic extent of colitis and presence of other inflammatory disord …
Inflammatory bowel disease and the elderly: a review.
Taleban S, Colombel JF, Mohler MJ, Fain MJ. Taleban S, et al. J Crohns Colitis. 2015 Jun;9(6):507-15. doi: 10.1093/ecco-jcc/jjv059. Epub 2015 Apr 13. J Crohns Colitis. 2015. PMID: 25870198 Review.
Dendrobium officinale polysaccharides alleviate colon tumorigenesis via restoring intestinal barrier function and enhancing anti-tumor immune response.
Liang J, Li H, Chen J, He L, Du X, Zhou L, Xiong Q, Lai X, Yang Y, Huang S, Hou S. Liang J, et al. Pharmacol Res. 2019 Oct;148:104417. doi: 10.1016/j.phrs.2019.104417. Epub 2019 Aug 29. Pharmacol Res. 2019. PMID: 31473343
However, it remains largely unknown whether DOPS can suppress AOM/DSS-induced colorectal cancer (CRC) model through its direct impact on intestinal barrier function and intestinal mucosal immunity. ...Treatment with 5-aminosalicylic acid (5
However, it remains largely unknown whether DOPS can suppress AOM/DSS-induced colorectal cancer (CRC) model through its direct …
Colorectal cancer prevention in patients with ulcerative colitis.
Lopez A, Pouillon L, Beaugerie L, Danese S, Peyrin-Biroulet L. Lopez A, et al. Best Pract Res Clin Gastroenterol. 2018 Feb-Apr;32-33:103-109. doi: 10.1016/j.bpg.2018.05.010. Epub 2018 May 16. Best Pract Res Clin Gastroenterol. 2018. PMID: 30060933 Review.
Surveillance colonoscopy program demonstrated its efficacy for reducing the incidence of colorectal cancer in ulcerative colitis. ...Several studies showed a decreased risk of colorectal cancer in ulcerative colitis patients treated with 5-am
Surveillance colonoscopy program demonstrated its efficacy for reducing the incidence of colorectal cancer in ulcerative colit …
5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
Zhang S, Fu J, Dogan B, Scherl EJ, Simpson KW. Zhang S, et al. J Antibiot (Tokyo). 2018 Nov;71(11):950-961. doi: 10.1038/s41429-018-0081-8. Epub 2018 Jul 26. J Antibiot (Tokyo). 2018. PMID: 30050110
5-aminosalicylate (5-ASA) is widely prescribed for the treatment of inflammatory bowel disease (IBD) and prevention of inflammation-associated colorectal cancer (CRC). ...These results suggest that 5-ASA may abrogate the proinflammatory and onco
5-aminosalicylate (5-ASA) is widely prescribed for the treatment of inflammatory bowel disease (IBD) and prevention of inflamm
Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X, Ma J, Wang K, Zhang H. Qiu X, et al. Oncotarget. 2017 Jan 3;8(1):1031-1045. doi: 10.18632/oncotarget.13715. Oncotarget. 2017. PMID: 27906680 Free PMC article. Review.
BACKGROUND AND AIMS: The chemopreventive effect of 5-aminosalicylic acid (5-ASA) in patients with inflammatory bowel disease (IBD) has been widely studied; however, the results remain conflicting. The aim of this study was to systematically review the …
BACKGROUND AND AIMS: The chemopreventive effect of 5-aminosalicylic acid (5-ASA) in patients with inflammatory b …
264 results
Jump to page
Feedback